Brief: Jazz Pharmaceuticals Showcases New Clinical And Translational Data For Modeyso
11/11/2025 12:47
Nov 11 (Reuters) - Jazz Pharmaceuticals PLC JAZZ.O: JAZZ PHARMACEUTICALS SHOWCASES NEW CLINICAL AND TRANSLATIONAL DATA FOR MODEYSO™ (DORDAVIPRONE) IN H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA AT SNO 2025 Source text: ID:nPn1t4sQja Further company coverage: JAZZ.O ((reuters.briefs@thomsonreuters.com;))
Recent news on Jazz Pharmaceuticals
See all newsBrief: Jazz Pharmaceuticals Enters Amendment No. 4 To Credit Agreement On Sept 23, 2026
U.S. STOCKS ON THE MOVE-BWX Technologies, Synopsys,Burlington Stores
U.S. STOCKS ON THE MOVE-Jazz Pharmaceuticals, Celularity, Infleqtion
Jazz Pharma dips after upsized $1.1 bln convertible offering
Brief: Jazz Pharmaceuticals Announces Private Offering Of $1.0 Billion Of Exchangeable Senior Notes Due 2032